Literature DB >> 14598865

Chemical modification of proteins by lipids in diabetes.

John W Baynes1.   

Abstract

Advanced glycation and lipoxidation end-products (AGE/ALE) increase in tissue proteins with age and at an accelerated rate in diabetes. This Review focuses on the nature and source of AGEs/ALEs and the factors affecting their formation in tissue and plasma proteins. Lipids are identified as an important source of chemical modification of proteins in diabetes, and the role of diabetes, dyslipidemia and renal disease in formation of AGEs/ALEs is reviewed. The article concludes with a discussion of ELISA assays for AGEs/ALEs and the merits of measuring AGEs/ALEs in the clinical laboratory.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14598865     DOI： 10.1515/CCLM.2003.179

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN： 1434-6621            Impact factor:   3.694


  15 in total

1.  Optoacoustic detection of tissue glycation.

Authors:  Ara Ghazaryan; Murad Omar; George J Tserevelakis; Vasilis Ntziachristos
Journal:  Biomed Opt Express       Date:  2015-07-31       Impact factor: 3.732

2.  Novel role for thioredoxin reductase-2 in mitochondrial redox adaptations to obesogenic diet and exercise in heart and skeletal muscle.

Authors:  Kelsey H Fisher-Wellman; Taylor A Mattox; Kathleen Thayne; Lalage A Katunga; Justin D La Favor; P Darrell Neufer; Robert C Hickner; Christopher J Wingard; Ethan J Anderson
Journal:  J Physiol       Date:  2013-04-22       Impact factor: 5.182

3.  Below the radar: advanced glycation end products that detour "around the side". Is HbA1c not an accurate enough predictor of long term progression and glycaemic control in diabetes?

Authors:  Josephine M Forbes; Georgia Soldatos; Merlin C Thomas
Journal:  Clin Biochem Rev       Date:  2005-11

Review 4.  Understanding RAGE, the receptor for advanced glycation end products.

Authors:  Angelika Bierhaus; Per M Humpert; Michael Morcos; Thoralf Wendt; Triantafyllos Chavakis; Bernd Arnold; David M Stern; Peter P Nawroth
Journal:  J Mol Med (Berl)       Date:  2005-08-24       Impact factor: 4.599

Review 5.  The Role of Nonenzymatic Post-translational Protein Modifications in Uremic Vascular Calcification.

Authors:  Kenneth Lim; Sahir Kalim
Journal:  Adv Chronic Kidney Dis       Date:  2019-11       Impact factor: 3.620

6.  A C. elegans Model for the Study of RAGE-Related Neurodegeneration.

Authors:  Adi Pinkas; Kun He Lee; Pan Chen; Michael Aschner
Journal:  Neurotox Res       Date:  2018-06-04       Impact factor: 3.911

Review 7.  The cardiovascular effects of chronic hypoestrogenism in amenorrhoeic athletes: a critical review.

Authors:  Emma O'Donnell; Mary Jane De Souza
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

8.  Modulation of the cellular expression of circulating advanced glycation end-product receptors in type 2 diabetic nephropathy.

Authors:  Karly C Sourris; Brooke E Harcourt; Sally A Penfold; Felicia Y T Yap; Amy L Morley; Philip E Morgan; Michael J Davies; Scott T Baker; George Jerums; Josephine M Forbes
Journal:  Exp Diabetes Res       Date:  2011-01-05

9.  The impact of salsalate treatment on serum levels of advanced glycation end products in type 2 diabetes.

Authors:  Joshua I Barzilay; Kathleen A Jablonski; Vivian Fonseca; Steven E Shoelson; Allison B Goldfine; Christopher Strauch; Vincent M Monnier
Journal:  Diabetes Care       Date:  2013-11-19       Impact factor: 19.112

10.  Kolaviron improved resistance to oxidative stress and inflammation in the blood (erythrocyte, serum, and plasma) of streptozotocin-induced diabetic rats.

Authors:  Omolola R Ayepola; Nicole L Brooks; Oluwafemi O Oguntibeju
Journal:  ScientificWorldJournal       Date:  2014-03-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.